|
| 37503026 | RBD-based high affinity ACE2 antagonist limits SARS-CoV-2 replication in upper and lower airways. | | 2023 |
| 37796123 | Multiple mutations of SARS-CoV-2 Omicron BA.2 variant orchestrate its virological characteristics. | J Virol | 2023 |
| 37193706 | Virological characteristics of the SARS-CoV-2 XBB variant derived from recombination of two Omicron subvariants. | | 2023 |
| 37114129 | Paradoxical activation of chronic lymphocytic leukemia cells by ruxolitinib and . | | 2023 |
| 36736338 | Enhanced transmissibility, infectivity, and immune resistance of the SARS-CoV-2 omicron XBB.1.5 variant. | | 2023 |
| 37506197 | Modulation of type I interferon responses potently inhibits SARS-CoV-2 replication and inflammation in rhesus macaques. | Sci Immunol | 2023 |
| 35081335 | SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses. | Cell | 2022 |
| 35711666 | Perspectives: SARS-CoV-2 Spike Convergent Evolution as a Guide to Explore Adaptive Advantage. | Frontiers in Cellular and Infection Microbiology | 2022 |
| 36157590 | Diffusion of small molecule drugs is affected by surface interactions and crowder proteins. | iScience | 2022 |
| 35568035 | Virological characteristics of the SARS-CoV-2 Omicron BA.2 spike. | Cell | 2022 |
| 36198317 | Virological characteristics of the SARS-CoV-2 Omicron BA.2 subvariants, including BA.4 and BA.5. | Cell | 2022 |
| 35608934 | Gelatin Stabilizes Nebulized Proteins in Pulmonary Drug Delivery against COVID-19. | ACS Biomaterials Science and Engineering | 2022 |
| 36320402 | Protein quaternary structures in solution are a mixture of multiple forms. | Chem Sci | 2022 |
| 35921522 | Genetically Engineered MRI-Trackable Extracellular Vesicles as SARS-CoV-2 Mimetics for Mapping ACE2 Binding . | ACS Nano | 2022 |
| 35597550 | In vitro Evolution of Uracil Glycosylase Towards DnaKJ and GroEL Binding Evolves Different Misfolded States. | Journal of Molecular Biology | 2022 |
| 36507224 | The SARS-CoV-2 spike S375F mutation characterizes the Omicron BA.1 variant. | iScience | 2022 |
| 34968415 | The SARS-CoV-2 Lambda variant exhibits enhanced infectivity and immune resistance. | Cell Rep | 2022 |
| 34826176 | De novo developed protein binders mimicking Interferon lambda signaling. | FEBS J | 2022 |
| 34809429 | A Protein-Engineered, Enhanced Yeast Display Platform for Rapid Evolution of Challenging Targets. | ACS Synthetic Biology | 2021 |
| 34171266 | SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity. | Cell Host Microbe | 2021 |
| 34196543 | Protein Engineering in the Design of Protein-Protein Interactions: SARS-CoV-2 Inhibitors as a Test Case. | Biochemistry | 2021 |
| 33647289 | Line-FRAP, A Versatile Method to Measure Diffusion Rates In Vitro and In Vivo. | Journal of Molecular Biology | 2021 |
| 34400835 | SARS-CoV-2 variant prediction and antiviral drug design are enabled by RBD in vitro evolution. | Nat Microbiol | 2021 |
| 34981049 | Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses. | bioRxiv | 2021 |
| 34437657 | SARS-CoV-2 suppresses IFNβ production mediated by NSP1, 5, 6, 15, ORF6 and ORF7b but does not suppress the effects of added interferon. | PLoS Pathogens | 2021 |
| 34890433 | Correction: SARS-CoV-2 suppresses IFNβ production mediated by NSP1, 5, 6, 15, ORF6 and ORF7b but does not suppress the effects of added interferon. | PLoS Pathogens | 2021 |
| 34813358 | IFNAR1 and IFNAR2 play distinct roles in initiating type I interferon-induced JAK-STAT signaling and activating STATs. | Science Signaling | 2021 |
| 33117408 | The Role of Type I Interferons in the Pathogenesis and Treatment of COVID-19. | Frontiers in Immunology | 2020 |
| 31341069 | Reply to Hasenkrug et al., "Different Biological Activities of Specific Interferon Alpha Subtypes". | mSphere | 2019 |
| 31606122 | Competing Ligands Can Both Obstruct and Enhance Protein-Complex Formation. | Biophysical Journal | 2019 |
| 30760614 | Dose-Dependent Differences in HIV Inhibition by Different Interferon Alpha Subtypes While Having Overall Similar Biologic Effects. | mSphere | 2019 |
| 31207241 | CRISPR/Cas9-based Knockout Strategy Elucidates Components Essential for Type 1 Interferon Signaling in Human HeLa Cells. | Journal of Molecular Biology | 2019 |
| 29324226 | Human-Specific Adaptations in Vpu Conferring Anti-tetherin Activity Are Critical for Efficient Early HIV-1 Replication In Vivo. | Cell Host Microbe | 2018 |
| 30142226 | Type I IFN signaling blockade by a PASylated antagonist during chronic SIV infection suppresses specific inflammatory pathways but does not alter T cell activation or virus replication. | PLoS Pathog | 2018 |
| 29671590 | Selecting for Fast Protein-Protein Association As Demonstrated on a Random TEM1 Yeast Library Binding BLIP. | Biochemistry | 2018 |
| 28289098 | The molecular basis for differential type I interferon signaling. | Journal of Biological Chemistry | 2017 |
| 28648616 | Dynamic Modulation of Binding Affinity as a Mechanism for Regulating Interferon Signaling. | J Mol Biol | 2017 |
| 28784664 | Quantifying enzyme activity in living cells. | Journal of Biological Chemistry | 2017 |
| 29211984 | Promiscuous Protein Binding as a Function of Protein Stability. | Structure | 2017 |
| 27744288 | Direct determination of enzyme kinetic parameters from single reactions using a new progress curve analysis tool. | Protein Engineering, Design and Selection | 2017 |
| 27917878 | Spatiotemporal control of interferon-induced JAK/STAT signalling and gene transcription by the retromer complex. | Nat Commun | 2016 |
| 26679999 | Type I Interferon Signaling Is Decoupled from Specific Receptor Orientation through Lenient Requirements of the Transmembrane Domain. | Journal of Biological Chemistry | 2016 |
| 27956635 | Low-stringency selection of TEM1 for BLIP shows interface plasticity and selection for faster binders. | Proceedings of the National Academy of Sciences of the United States of America | 2016 |
| 26158644 | Fine Tuning of a Type 1 Interferon Antagonist. | PLoS ONE | 2015 |
| 25687684 | The molecular basis for functional plasticity in type I interferon signaling. | Trends in Immunology | 2015 |
| 25721402 | A robust type I interferon gene signature from blood RNA defines quantitative but not qualitative differences between three major IFNβ drugs in the treatment of multiple sclerosis. | Hum Mol Genet | 2015 |
| 25193661 | Enhanced in vivo efficacy of a type I interferon superagonist with extended plasma half-life in a mouse model of multiple sclerosis. | Journal of Biological Chemistry | 2014 |
| 24416207 | Bridging the species divide: transgenic mice humanized for type-I interferon response. | PLoS ONE | 2014 |
| 25043006 | Type I interferon responses in rhesus macaques prevent SIV infection and slow disease progression. | Nature | 2014 |
| 24866020 | Multifaceted activities of type I interferon are revealed by a receptor antagonist. | Sci Signal | 2014 |